MASD in Wound Care: Prevention and Management Protocol

MASD in Wound Care: Recognition and Management

Moisture-associated skin damage is one of the most frequently encountered — and most frequently misclassified — conditions in wound care practice. MASD occurs when prolonged exposure to moisture causes inflammation, maceration, and breakdown of the skin. The moisture source determines the MASD subtype: urine and stool cause incontinence-associated dermatitis (IAD), perspiration trapped in skin folds causes intertriginous dermatitis (ITD), wound exudate causes periwound moisture damage, and ostomy effluent causes peristomal moisture damage.

The clinical and regulatory problem with MASD is not its treatment — barrier products and moisture management are straightforward. The problem is its misclassification as a pressure injury. A sacral MASD lesion documented as a Stage 2 pressure injury triggers a cascade of consequences: facility quality metrics, CMS reporting, potential survey deficiency, and a care plan built around the wrong etiology. Getting the differential diagnosis right is the single most important clinical skill in MASD management.

---

MASD Subtypes and Assessment

Incontinence-Associated Dermatitis (IAD)

IAD is the most common MASD subtype. Urine and stool — particularly liquid stool — contain enzymes and irritants that break down the epidermal barrier.

Clinical presentation:

• Diffuse erythema in areas of moisture contact (sacrum, buttocks, perineum, inner thighs, labial folds)
• Skin appears shiny, wet, or macerated
• Irregular, diffuse borders — NOT confined to a bony prominence
• Partial-thickness skin loss with shallow, moist erosions
• Patient reports burning or stinging, not deep pressure pain
• Bilateral or symmetrical involvement is common

Severity grading:

• Category 1: Intact skin with erythema, edema, or both
• Category 2: Partial-thickness skin loss with erosion, denudation, blistering, or secondary infection (candidasis is common)

Intertriginous Dermatitis (ITD)

ITD occurs in skin folds where trapped perspiration and friction cause breakdown. Common sites: submammary, abdominal pannus, groin folds, axillae, interdigital spaces.

Clinical presentation:

• Mirror-image erythema on opposing skin fold surfaces
• Maceration, satellite papules (suspect Candida), foul odor
• Linear fissuring at the depth of the skin fold
• Often coexists with fungal infection — inspect for satellite lesions

Periwound Moisture Damage

Excessive wound exudate macerizes intact periwound skin, creating an expanding zone of skin breakdown around the wound itself.

Clinical presentation:

• White, boggy, wrinkled skin immediately surrounding the wound edge
• Wound margins become indistinct as macerated skin merges with the wound bed
• May enlarge the wound by converting intact periwound skin to a wound surface
• Common with highly exudative wounds under occlusive dressings

Achieving the right moisture balance in the wound bed while protecting the periwound skin is the core treatment challenge for exudative wounds.

---

MASD vs. Pressure Injury: Differential Diagnosis

This is the highest-stakes differentiation in wound care documentation. Both can present on the sacrum, both can involve partial-thickness skin loss, and both occur in immobile patients. Misclassification goes in both directions and both are problematic.

Feature	MASD (IAD)	Pressure Injury
Location	Diffuse over moisture-exposed area	Over bony prominence
Borders	Irregular, diffuse, poorly defined	Distinct wound margins
Depth	Superficial, partial-thickness	Stage-dependent, can be full-thickness
Pain character	Burning, stinging	Deep, pressure-related
Distribution	Bilateral, follows moisture contact	Unilateral, localized
Onset	Rapid (hours to days with exposure)	Gradual (days to weeks)
Surrounding skin	Macerated, shiny, wet	May have induration, callused edge

Critical documentation point: When MASD and pressure injury coexist — which is common, because moisture is a pressure injury risk factor — document BOTH diagnoses separately. A sacral pressure injury in an incontinent patient does not become "just IAD," and IAD does not become "a pressure injury" because it happens to sit over the sacrum.

---

Prevention Protocol

Prevention of MASD is more effective and less costly than treatment. The prevention protocol centers on three principles: cleanse, protect, contain.

Cleanse:

• Use pH-balanced (5.0–5.5) perineal cleansers, not soap and water
• Soap strips the skin's acid mantle and worsens moisture damage
• Cleanse at every incontinence episode, not on a schedule
• Pat dry — never rub macerated or inflamed skin

Protect:

• Apply moisture barrier products to intact skin at risk
• Dimethicone-based barriers for mild risk (light incontinence, perspiration)
• Zinc oxide or petrolatum-based barriers for moderate to severe risk (liquid stool, dual incontinence)
• Cyanoacrylate skin protectants (liquid skin barriers) for periwound protection and high-friction areas

Contain:

• Address the moisture source directly
• Incontinence: absorbent products sized correctly, bowel management system for liquid stool
• Wound exudate: appropriate dressing absorptive capacity, dressing change frequency matched to exudate volume
• Perspiration in skin folds: wicking fabrics, textile separators between opposing skin surfaces

---

Treatment Protocol for Established MASD

When prevention fails and MASD is established, treatment intensifies the prevention protocol and adds targeted interventions for damaged skin.

IAD Treatment

Category 1 (intact skin with inflammation):

• Gentle cleansing with pH-balanced cleanser
• Apply barrier cream or ointment (zinc oxide, dimethicone, or petrolatum) at every episode
• Reassess in 48–72 hours — if worsening, suspect fungal superinfection

Category 2 (partial-thickness loss or secondary infection):

• Same cleansing and barrier protocol
• If Candida suspected (satellite lesions, beefy red base): topical antifungal powder (nystatin or miconazole) applied UNDER the barrier cream
• For denuded skin: cyanoacrylate skin protectant creates a protective film over raw surfaces
• If bacterial superinfection: topical antimicrobial (mupirocin for focal, silver-based for broader involvement)

Periwound Maceration Treatment

• Reassess dressing absorptive capacity — upgrade to superabsorbent or add secondary absorbent layer
• Apply skin protectant (barrier film or cyanoacrylate) to periwound skin before applying primary dressing
• Consider window-paning with hydrocolloid strips around wound edge to protect periwound skin
• Adjust dressing change frequency to match exudate output

Detailed wound care documentation of MASD treatment is essential, particularly the differential diagnosis reasoning, to prevent misclassification on audit.

---

ICD-10 Coding for MASD

MASD has specific ICD-10 codes. Using pressure injury codes for MASD lesions is a documentation error.

Condition	ICD-10 Code
Irritant contact dermatitis (IAD)	L24.9
Diaper dermatitis (applicable in adult incontinence)	L22
Intertrigo (ITD)	L30.4
Candidiasis of skin and nail	B37.2
Maceration of skin	L98.8 (other specified skin disorders)

---

Key Takeaways

• MASD is not a pressure injury: diffuse, irregular borders over moisture-exposed areas versus distinct margins over bony prominences — getting this differential right is the highest-priority documentation task
• When MASD and pressure injury coexist in the same patient, document both diagnoses separately with distinct assessment findings for each
• Prevention follows the cleanse-protect-contain framework: pH-balanced cleansers, dimethicone or zinc oxide barriers, and source containment of moisture
• Periwound maceration management requires matching dressing absorptive capacity to exudate volume and applying barrier products to intact periwound skin
• Use MASD-specific ICD-10 codes (L24.9, L22, L30.4) rather than pressure injury codes for moisture-related skin damage